Please login to the form below

Not currently logged in
Email:
Password:

Genocea Biosciences

This page shows the latest Genocea Biosciences news and features for those working in and with pharma, biotech and healthcare.

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II

Genital herpes vaccine candidate promising in phase II. Genocea Biosciences’ GEN-003 found to reduce recurrence and transmission of the virus. ... The vaccine - called GEN-003 and developed by Genocea Biosciences - is a T cell-enabled therapeutic

Latest news

  • Vical's genital herpes vaccine flunks trial Vical's genital herpes vaccine flunks trial

    outbreaks. Last year, Sanofi set up an alliance with Immune Design to develop a therapeutic vaccine for HSV-2 based on their two vaccine candidates, while Genocea Biosciences, Agenus and Tomegavax

More from news
Approximately 1 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics